ASCENDIS PHARMA A/S

CUSIP: 04351PAD3 Class: NOTE 2.250% 4/0

Nicholas Investment Partners, LP's Holding History (CIK: 0001389574)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 6,035,000 Value ($000) $8,550 Avg Close — Range —
Q3 2025
Shares 6,035,000 Value ($000) $8,208 Avg Close — Range —
Q2 2025
Shares 4,285,000 Value ($000) $5,357 Avg Close — Range —
Q1 2025
Shares 4,285,000 Value ($000) $5,078 Avg Close — Range —
Q4 2024
Shares 4,285,000 Value ($000) $4,703 Avg Close — Range —
Q3 2024
Shares 4,285,000 Value ($000) $4,980 Avg Close — Range —
Q2 2024
Shares 3,500,000 Value ($000) $3,891 Avg Close — Range —
Q1 2024
Shares 3,500,000 Value ($000) $4,027 Avg Close — Range —
Q4 2023
Shares 3,000,000 Value ($000) $3,068 Avg Close — Range —
Q3 2023
Shares 3,000,000 Value ($000) $2,738 Avg Close — Range —
Q2 2023
Shares 3,000,000 Value ($000) $2,723 Avg Close — Range —